-
ACLA Comments on Medicare and Medicaid Programs, Clinical Laboratory Improvement Amendments and Patient Protection and Affordable Care Act Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency [CMS-3401-IFC]
-
ACLA Comments on 2021 ONC Interoperability Standards Advisory (ISA)
-
ACLA Comments on VALID Act
-
ACLA Letter to Bill Gates
-
ACLA Comments on MedPAC CLFS Session – September 2020
-
Testing Fund Stakeholder Letter
-
ACLA Letter to Chairman Lamar Alexander on Pandemic Response White Paper
-
Stakeholder Letter Calling For Extension of Public Health Emergency Declaration
-
ACLA Letter to HHS on Data Reporting
-
ACLA Letter to CDC on Antibody Guidance
